Sponsor pipeline

Elicio Therapeutics clinical trial pipeline

Get alerts when Elicio Therapeutics's trials change

1 active trials 0 recruiting 2 disease areas

Data updated daily from ClinicalTrials.gov, last refresh 2026-08-28

Active trials by phase

Phase 1/2
1

Active trials

NCT IDTitleConditionStatusUpdated
Phase 1/2
NCT05726864 A Study of ELI-002 7P in Subjects With KRAS/NRAS Mutated Solid Tumors Pancreatic Ductal Adenocarcinoma Active, Not Recruiting 2026-07-10

Disease areas by active trials

Get alerts when Elicio Therapeutics's trials change
Status changes, date slips, and new filings: detected daily, delivered to your inbox.
Start monitoring free